{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:55:49Z","timestamp":1791996949549,"version":"4.4.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T00:00:00Z","timestamp":1692316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T00:00:00Z","timestamp":1692316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To analyze the\u00a0diagnostic value of computed tomography (CT), magnetic resonance imaging (MRI) combined with serum lactate dehydrogenase (LDH), neuron-specific enolase (NSE), carcinoembryonic antigen (CEA), and N-myc (MYCN) in the diagnosis of pediatric neuroblastoma.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Fifty-two children diagnosed with neuroblastoma were selected as the neuroblastoma group. During the same period, 52 children who visited our hospital with abdominal distension, diarrhea, constipation, and vomiting but were finally excluded from neuroblastoma were selected as the control group. CT and MRI were performed on all children.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Fifty-two cases of neuroblastoma of the central nervous system were confirmed by pathological examination. The levels of LDH, NSE, CEA, and MYCN in the neuroblastoma group were clearly higher than those in the control group (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). The results of CT and MRI combined with serum LDH, NSE, CEA, and MYCN were false positive in 10 cases and false negative in 6 cases, which were consistent with the pathological results. The sensitivity of CT and MRI combined with serum LDH, NSE, CEA, and MYCN in the diagnosis of neuroblastoma was notably higher than that of the three alone (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The imaging findings of CT and MRI in children with central nervous system neuroblastoma were definitely characteristic. MRI had higher diagnostic value than CT. The diagnostic value of CT and MRI combined with serum LDH, NSE, CEA, and MYCN was improved to some extent.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12957-023-03131-5","type":"journal-article","created":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T01:01:56Z","timestamp":1692320516000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Diagnostic value of CT and MRI combined with serum LDH, NSE, CEA, and MYCN in pediatric neuroblastoma"],"prefix":"10.1186","volume":"21","author":[{"given":"Jumei","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiajuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihua","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,18]]},"reference":[{"key":"3131_CR1","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s00247-018-4117-9","volume":"48","author":"AM Chen","year":"2018","unstructured":"Chen AM, Trout AT, Towbin AJ. A review of neuroblastoma image-defined risk factors on magnetic resonance imaging. Pediatr Radiol. 2018;48:1337\u201347.","journal-title":"Pediatr Radiol"},{"key":"3131_CR2","doi-asserted-by":"publisher","first-page":"5309","DOI":"10.1038\/s41467-021-24870-7","volume":"12","author":"OC Bedoya-Reina","year":"2021","unstructured":"Bedoya-Reina OC, Li W, Arceo M, Plescher M, Bullova P, Pui H, et al. Single-nuclei transcriptomes from human adrenal gland reveal distinct cellular identities of low and high-risk neuroblastoma tumors. Nat Commun. 2021;12:5309.","journal-title":"Nat Commun"},{"key":"3131_CR3","doi-asserted-by":"publisher","first-page":"578","DOI":"10.18295\/squmj.4.2021.032","volume":"21","author":"A Al-Battashi","year":"2021","unstructured":"Al-Battashi A, Al-Rahbi A, Al-Rawahi A, Mamdouh M, Al-Ghaithi I, Ramadhan FA. Neuroblastoma among Omani children: clinical characteristics and survival outcome from a dedicated centre. Sultan Qaboos Univ Med J. 2021;21:578\u201384.","journal-title":"Sultan Qaboos Univ Med J"},{"key":"3131_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ijporl.2017.04.013","volume":"97","author":"S Alvi","year":"2017","unstructured":"Alvi S, Karadaghy O, Manalang M, Weatherly R. Clinical manifestations of neuroblastoma with head and neck involvement in children. Int J Pediatr Otorhinolaryngol. 2017;97:157\u201362.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"3131_CR5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1097\/MPH.0000000000000242","volume":"37","author":"H Boutroux","year":"2015","unstructured":"Boutroux H, Garel C, Jouannic JM, Forin V, Mitanchez D, Fasola S, Leverger G. Neonatal dumbbell neuroblastoma: a case report, from prenatal diagnosis to postnatal strategy. J Pediatr Hematol Oncol. 2015;37:328\u20139.","journal-title":"J Pediatr Hematol Oncol"},{"key":"3131_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3941\/jrcr.v12i3.3300","volume":"12","author":"A Chaturvedi","year":"2018","unstructured":"Chaturvedi A, Katzman PJ, Franco A. Neonatal neuroblastoma 4s with diffuse liver metastases (Pepper syndrome) without an adrenal\/extraadrenal primary identified on imaging. J Radiol Case Rep. 2018;12:18\u201327.","journal-title":"J Radiol Case Rep"},{"key":"3131_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1259\/bjr\/31861984","volume":"84","author":"CM Chu","year":"2011","unstructured":"Chu CM, Rasalkar DD, Hu YJ, Cheng FW, Li CK, Chu WC. Clinical presentations and imaging findings of neuroblastoma beyond abdominal mass and a review of imaging algorithm. Br J Radiol. 2011;84:81\u201391.","journal-title":"Br J Radiol"},{"key":"3131_CR8","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.canrad.2015.05.030","volume":"19","author":"M Dore","year":"2015","unstructured":"Dore M, Mahe MA, Corradini N, Demoor-Goldschmidt C. Neonatal neuroblastoma complicated with a threatening tumoral hepatomegaly treated by irradiation: no sequel 20 years later. Cancer Radiother. 2015;19:749\u201351.","journal-title":"Cancer Radiother"},{"key":"3131_CR9","first-page":"3624847","volume":"2017","author":"L Gely","year":"2017","unstructured":"Gely L, Lugo-Vicente H, Correa-Rivas M, Bouet K, Reyes Bou Z, Suleiman M, et al. Neonatal sacrococcygeal neuroblastoma mimicking a teratoma. Case Rep Pediatr. 2017;2017:3624847.","journal-title":"Case Rep Pediatr"},{"issue":"9","key":"3131_CR10","first-page":"114","volume":"5","author":"V Smith","year":"2018","unstructured":"Smith V, Foster J. High-risk neuroblastoma treatment review. Children (Basel). 2018;5(9):114.","journal-title":"Children (Basel)"},{"issue":"2","key":"3131_CR11","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1148\/rg.2018170132","volume":"38","author":"CC Swift","year":"2018","unstructured":"Swift CC, Eklund MJ, Kraveka JM, Alazraki AL. Updates in diagnosis, management, and treatment of neuroblastoma. Radiographics. 2018;38(2):566\u201380.","journal-title":"Radiographics"},{"issue":"4","key":"3131_CR12","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s43018-022-00355-4","volume":"3","author":"H Alborzinia","year":"2022","unstructured":"Alborzinia H, Florez AF, Kreth S, Br\u00fcckner LM, Yildiz U, Gartlgruber M, et al. MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis. Nat Cancer. 2022;3(4):471\u201385.","journal-title":"Nat Cancer"},{"issue":"1","key":"3131_CR13","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/1878-0261.12588","volume":"14","author":"S Chava","year":"2020","unstructured":"Chava S, Reynolds CP, Pathania AS, Gorantla S, Poluektova LY, Coulter DW, et al. miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastoma. Mol Oncol. 2020;14(1):180\u201396.","journal-title":"Mol Oncol"},{"key":"3131_CR14","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1158\/2159-8290.CD-21-0385","volume":"12","author":"AD Durbin","year":"2022","unstructured":"Durbin AD, Wang T, Wimalasena VK, Zimmerman MW, Li D, Dharia NV, et al. EP300 selectively controls the enhancer landscape of MYCN-amplified neuroblastoma. Cancer Discov. 2022;12:730\u201351.","journal-title":"Cancer Discov"},{"key":"3131_CR15","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1158\/1078-0432.CCR-18-3791","volume":"25","author":"H Li","year":"2019","unstructured":"Li H, Li J, Chen L, Qi S, Yu S, Weng Z, et al. HERC3-mediated SMAD7 ubiquitination degradation promotes autophagy-induced EMT and chemoresistance in glioblastoma. Clin Cancer Res. 2019;25:3602\u201316.","journal-title":"Clin Cancer Res"},{"key":"3131_CR16","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/jjco\/hyx176","volume":"48","author":"A Nakagawara","year":"2018","unstructured":"Nakagawara A, Li Y, Izumi H, Muramori K, Inada H, Nishi M. Neuroblastoma. Jpn J Clin Oncol. 2018;48:214\u201341.","journal-title":"Jpn J Clin Oncol"},{"issue":"4","key":"3131_CR17","first-page":"321","volume":"4","author":"J Takita","year":"2021","unstructured":"Takita J. Molecular basis and clinical features of neuroblastoma. JMA J. 2021;4(4):321\u201331.","journal-title":"JMA J"},{"issue":"4","key":"3131_CR18","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.celrep.2016.06.052","volume":"16","author":"D Ribeiro","year":"2016","unstructured":"Ribeiro D, Klarqvist MR, Westermark U, et al. Regulation of nuclear hormone receptors by MYCN-driven miRNAs impacts neural differentiation and survival in neuroblastoma patients. Cell Rep. 2016;16(4):979\u201393.","journal-title":"Cell Rep"},{"key":"3131_CR19","doi-asserted-by":"crossref","unstructured":"Challagundla KB, Reynolds P, Gorantla S, et al. Abstract 781: the tumor suppressive microRNA-15 family targets MYCN in neuroblastoma. In: Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA.2019.D.","DOI":"10.1158\/1538-7445.AM2019-781"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-023-03131-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-023-03131-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-023-03131-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T22:19:55Z","timestamp":1700259595000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-023-03131-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,18]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3131"],"URL":"https:\/\/doi.org\/10.1186\/s12957-023-03131-5","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,18]]},"assertion":[{"value":"29 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Yantaishan Hospital. Signed written informed consent was obtained from the patients and\/or guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"251"}}